Skip to main content

Roche’s virtual analyst event during ESMO IO

Roche has hosted a virtual event on Friday, 10 December 2021.

agenda
Agenda
WelcomeKarl Mahler, Head of Investor Relations
CITYSCAPE updated analysis: Tiragolumab + Tecentriq in 1L NSCLCRaymond Meng, M.D., Ph.D. - Global Development Leader Tiragolumab
Tiragolumab development overviewHeather Stevens, MBA, MPH - Life Cycle Leader, Tiragolumab
Q&A

Webinar Replay

InvestorsPast IR Events
View more Events

Downloads

Download Presentation

PDF

Discover more

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions

  • Finance Information Tool

    Investors

    Access the finance information tool for the latest Roche financial data.